Clinical trials
Phase 2 Atherosclerosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genentech, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Beijing Inno Medicine Co., Ltd. | 1 |
| Dr. Amer Johri | 1 |
| GlaxoSmithKline | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Montreal Heart Institute | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 13 |
| Cardiovascular Diseases | 3 |
| Coronary Artery Disease | 3 |
| Hyperlipoproteinemia Type II | 2 |
| Coronary Disease | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
| Glucose Intolerance | 1 |
| Heart Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.